What is Lactase From Saccharomyces Fragilis?
Lactase from Saccharomyces fragilis is an enzyme produced by the yeast species Saccharomyces fragilis (also known as Kluyveromyces fragilis). This enzyme catalyzes the hydrolysis of lactose, a disaccharide found in milk and dairy products, into its component monosaccharides: glucose and galactose. The enzyme is obtained through fermentation processes and represents a biotechnologically produced food enzyme.
Common Uses
The primary application of lactase from Saccharomyces fragilis is in the production of lactose-reduced and lactose-free dairy products. These products are designed for consumers with lactose intolerance, a condition affecting a significant portion of the global population, particularly among adults of non-Northern European descent. Common applications include:
- Lactose-free milk
- Lactose-reduced cheese and yogurt
- Lactose-free ice cream and desserts
- Whey protein products
- Other dairy-based beverages and products
The enzyme is added during processing and typically remains in the final product at minimal levels, as much of it is inactivated during heat treatment or removed through processing steps.
Safety Assessment
Lactase from Saccharomyces fragilis has not been formally evaluated by the FDA's GRAS (Generally Recognized as Safe) program, though it is used in food production in various jurisdictions. The enzyme itself is a protein that is readily digested in the human gastrointestinal tract, which is typical for enzymes used in food processing.
According to FDA records, there have been zero reported adverse events associated with this additive and zero product recalls linked to its use. This absence of adverse event reports, combined with the lack of recalls, suggests no significant safety concerns have emerged from its use in the food supply.
The source organism, Saccharomyces fragilis, is not known to be pathogenic or toxigenic. The yeast is commonly used in various industrial fermentation processes. The enzyme itself poses minimal risk of allergenicity, though individuals with severe yeast allergies might theoretically experience sensitivity, though documented cases are extremely rare.
Regulatory Status
The regulatory status of lactase from Saccharomyces fragilis varies by region. In the European Union, this enzyme may be authorized under food enzyme regulations (EC No. 1332/2008) following EFSA assessments. In the United States, while not GRAS-listed, it may be used under FDA regulations governing food enzymes, though specific pre-market approval or notification may be required depending on manufacturing and use conditions.
Different countries maintain their own enzyme approval lists and specifications. Manufacturers using this enzyme in food products must comply with regulations in their target markets, which may include documentation of the production organism's safety, manufacturing process controls, and specifications for the final enzyme preparation.
Key Studies
Scientific literature on lactase enzymes from Saccharomyces fragilis is limited compared to lactase from other sources like Aspergillus oryzae or Kluyveromyces lactis. However, lactose hydrolysis by yeast-derived lactases is well-established biochemically. The enzyme exhibits optimal activity at neutral to slightly acidic pH and moderate temperatures typical of dairy processing.
General enzyme safety assessments indicate that protein-based enzymes used in food processing are broken down during digestion and pose minimal toxicological concern. The absence of chronic toxicity studies specifically for this enzyme reflects its generally recognized safe status within industrial practice rather than evidence of risk.